Axiogenesis Announces Worldwide, Exclusive Distribution Agreement with Lonza Cologne 03 March 2010 The agreement includes Axiogenesis’s current product and service portfolio, including Cor.At® mouse embryonic stem cell-derived cardiomyocytes.
Press Day Focuses on Science Innovation 23 February 2010 A Press Day held at Clare College, Cambridge this week offered editors from more than 30 science publications the opportunity to learn more about a host of innovative products and services that will be seeking to make the headlines in 2010 in the laboratory, life science and biotechnology sectors.
ALDH Associated with Worse Overall Survival in Patients with Pancreatic Adenocarcinoma 22 February 2010 Johns Hopkins researchers publish findings of the new study online on February 17 in the Journal of the National Cancer Institute.
New Tool Illuminates Connections Between Stem Cells and Cancer 22 February 2010 HHMI researchers have a new tool to understand how cancers grow - and with it a new opportunity to identify novel cancer drugs.
NIH Stem Cell Guidelines Should be Modified, UCSF Team Reports 22 February 2010 The team urge that guidelines be modified to better protect the rights of individuals donating egg or sperm to patients undergoing in vitro fertilization.
ReNeuron Receives Final Regulatory Approval to Commence Landmark Stroke Clinical Trial in UK 15 February 2010 The approval represents the final national regulatory step in taking the ReN001 therapy into patients in the UK.
MCG to Conduct First FDA-approved Stem Cell Trial in Pediatric Cerebral Palsy 15 February 2010 Study will include 40 children age 2-12 whose parents have stored cord blood at the Cord Blood Registry.
Morgridge Institute for Research Announces Scientific Leadership Team, Research Areas 11 February 2010 The institute has finalized its inaugural team to bring to life its mission of accelerating discovery to delivery to improve human health.